Clear descriptions of potential risks and side effects will be required under rules that go into effect Nov. 20, even as the ...
The hemoglobin elevating agent is being developed for the treatment of anemia associated with multiple diseases.
The Food and Drug Administration announced Wednesday that it would seek to pull a widely used ingredient in cough and cold medicines from the market, after the agency's scientists concluded that ...
today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for TLX101-CDx (Pixclara® 1), an agent for the imaging of glioma.
The Food and Drug Administration approved a drug produced by AbbVie for the treatment of late stage Parkinsons disease the company announced Thursday. The regulator approved Vyalev, also known as ...
Fadanelli is accused of lying to clients and employees about being a registered nurse and performing thousands of injections ...